UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 97

Sortiert nach

A new three dimensional biomimetic hydrogel to deliver factors secreted by human mesenchymal stem cells in spinal cord injury

Biomaterials, 2016-01, Vol.75, p.135-147

2016

Link zum Volltext

Verfügbarkeit prüfen

Macrophages are essential for maintaining a M2 protective response early after ischemic brain injury

Neurobiology of disease, 2016-12, Vol.96, p.284-293

2016

Link zum Volltext

Verfügbarkeit prüfen

Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells

Cancer research (Chicago, Ill.), 2010-03, Vol.70 (6), p.2235-2244

2010

Link zum Volltext

Verfügbarkeit prüfen

Combination of PI3K/mTOR Inhibitors: Antitumor Activity and Molecular Correlates

Cancer research (Chicago, Ill.), 2011-07, Vol.71 (13), p.4573-4584

2011

Link zum Volltext

Verfügbarkeit prüfen

Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors

Molecular cancer therapeutics, 2009-02, Vol.8 (2), p.449-457

2009

Link zum Volltext

Verfügbarkeit prüfen

Application of 3D Mass Spectrometry Imaging to TKIs

Clinical pharmacology and therapeutics, 2017-11, Vol.102 (5), p.748-751

2017

Link zum Volltext

Verfügbarkeit prüfen

FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients

Journal of experimental & clinical cancer research, 2017-05, Vol.36 (1), p.63-63, Article 63

2017

Link zum Volltext

Verfügbarkeit prüfen

Potential role of STAG1 mutations in genetic predisposition to childhood hematological malignancies

Blood cancer journal (New York), 2022-06, Vol.12 (6), p.88-88, Article 88

2022

Link zum Volltext

Verfügbarkeit prüfen

A systems biology approach to characterize the regulatory networks leading to trabectedin resistance in an in vitro model of myxoid liposarcoma

PloS one, 2012-04, Vol.7 (4), p.e35423

2012

Link zum Volltext

Verfügbarkeit prüfen

Chk1, but not Chk2 , is Involved in the Cellular Response to DNA Damaging Agents: Differential Activity in Cells Expressing, or not, p53

Cell cycle (Georgetown, Tex.), 2004-09, Vol.3 (9), p.1175-1179

2004

Link zum Volltext

Verfügbarkeit prüfen

Counteracting roles of MHCI and CD8+ T cells in the peripheral and central nervous system of ALS SOD1G93A mice

Molecular neurodegeneration, 2018-08, Vol.13 (1), p.42-42, Article 42

2018

Link zum Volltext

Verfügbarkeit prüfen

Selective Effects of the Anticancer Drug Yondelis (ET-743) on Cell-Cycle Promoters

Molecular pharmacology, 2005-11, Vol.68 (5), p.1496-1503

2005

Link zum Volltext

Verfügbarkeit prüfen

Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts

Molecular cancer therapeutics, 2004-02, Vol.3 (2), p.111-121

2004

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2352: Effect of inhibition of cell cycle versus transcription cyclin-dependent kinases (CDKs) in ovarian cancer cells

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2352-2352

2017

Link zum Volltext

Verfügbarkeit prüfen

Potential Role of STAG1 Mutations in Genetic Predisposition to Childhood Hemato-Oncological Diseases

Blood, 2021-11, Vol.138 (Supplement 1), p.1155-1155

2021

Link zum Volltext

Verfügbarkeit prüfen

Unique Features of the Mode of Action of ET‐743

The oncologist (Dayton, Ohio), 2002-01, Vol.7 (3), p.210-216

2002

Link zum Volltext

Verfügbarkeit prüfen

The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo

Biochemical pharmacology, 2010-04, Vol.79 (8), p.1141-1148

2010

Link zum Volltext

Verfügbarkeit prüfen

Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-κB

Oncotarget, 2018-04, Vol.9 (28), p.19929-19944

2018

Link zum Volltext

Verfügbarkeit prüfen

Antiangiogenic activity of trabectedin in myxoid liposarcoma: Involvement of host TIMP‐1 and TIMP‐2 and tumor thrombospondin‐1

International journal of cancer, 2015-02, Vol.136 (3), p.721-729

2015

Link zum Volltext

Verfügbarkeit prüfen

Tumor progression and metastatic dissemination in ovarian cancer after dose‐dense or conventional paclitaxel and cisplatin plus bevacizumab

International journal of cancer, 2018-11, Vol.143 (9), p.2187-2199

2018

Link zum Volltext

Verfügbarkeit prüfen

Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma

British journal of haematology, 2019-03, Vol.184 (6), p.1022-1025

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4821: The WEE1 inhibitor AZD-1775 has synergic activity with trabectedin or lurbinectedin in ovarian cancer cells

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4821-4821

2016

Link zum Volltext

Verfügbarkeit prüfen

DNA Damage Induces p53-dependent Down-regulation of hCHK1

The Journal of biological chemistry, 2001-04, Vol.276 (14), p.10641-10645

2001

Link zum Volltext

Verfügbarkeit prüfen

Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK‐8628 in malignant pleural mesothelioma xenografts

International journal of cancer, 2017-01, Vol.140 (1), p.197-207

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 97

Suche als RSS-Feed

Aktive Filter

KollektioneBooks on EBSCOhost

ThemaCell Biology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(91)

Publikationsform

Artikel
(96)
magazinearticle
(1)

Sprache

Englisch
(97)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(62)
Life Sciences & Biomedicine
(57)
Humans
(49)
Animals
(35)
Oncology
(32)
Mice
(31)
Biological And Medical Sciences
(28)
Female
(22)
Medical Sciences
(19)
Cell Line, Tumor
(18)
Flow Cytometry
(17)
Antineoplastic Agents
(16)
Pharmacology. Drug Treatments
(16)
Cell Cycle
(14)
Antineoplastic Agents - Pharmacology
(12)
Apoptosis
(10)
Cell Survival - Drug Effects
(10)
Fundamental And Applied Biological Sciences. Psychology
(10)
Tumor Cells, Cultured
(10)
Cell Line
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A new three dimensional biomimetic hydrogel to deliver factors secreted by human mesenchymal stem cells in spinal cord injury

Macrophages are essential for maintaining a M2 protective response early after ischemic brain injury

Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells

Combination of PI3K/mTOR Inhibitors: Antitumor Activity and Molecular Correlates

Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors

Application of 3D Mass Spectrometry Imaging to TKIs

FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients

Potential role of STAG1 mutations in genetic predisposition to childhood hematological malignancies

A systems biology approach to characterize the regulatory networks leading to trabectedin resistance in an in vitro model of myxoid liposarcoma

Chk1, but not Chk2 , is Involved in the Cellular Response to DNA Damaging Agents: Differential Activity in Cells Expressing, or not, p53

Counteracting roles of MHCI and CD8+ T cells in the peripheral and central nervous system of ALS SOD1G93A mice

Selective Effects of the Anticancer Drug Yondelis (ET-743) on Cell-Cycle Promoters

Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts

Early modulation of pro-inflammatory microglia by minocycline loaded nanoparticles confers long lasting protection after spinal cord injury

Abstract 2352: Effect of inhibition of cell cycle versus transcription cyclin-dependent kinases (CDKs) in ovarian cancer cells

Potential Role of STAG1 Mutations in Genetic Predisposition to Childhood Hemato-Oncological Diseases

Unique Features of the Mode of Action of ET‐743

The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo

Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-κB

Antiangiogenic activity of trabectedin in myxoid liposarcoma: Involvement of host TIMP‐1 and TIMP‐2 and tumor thrombospondin‐1

Tumor progression and metastatic dissemination in ovarian cancer after dose‐dense or conventional paclitaxel and cisplatin plus bevacizumab

Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma

Abstract 4821: The WEE1 inhibitor AZD-1775 has synergic activity with trabectedin or lurbinectedin in ovarian cancer cells

DNA Damage Induces p53-dependent Down-regulation of hCHK1

Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK‐8628 in malignant pleural mesothelioma xenografts

Aktive Filter

Suchergebnisse filtern